A vaccine is not too far for COVID-19

Shailesh Kumar Patel; Mamta Pathak; Ruchi Tiwari; Mohd Iqbal Yatoo; Yashpal Singh Malik; Ranjit Sah; Ali A. Rabaan; Khan Sharun; Kuldeep Dhama; D. Katterine Bonilla-Aldana; Alfonso J. Rodriguez-Morales

doi:10.3855/jidc.12744

A vaccine is not too far for COVID-19

Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Mohd Iqbal Yatoo, Yashpal Singh Malik, Ranjit Sah, Ali A. Rabaan, Khan Sharun, Kuldeep Dhama, D. Katterine Bonilla-Aldana, Alfonso J. Rodriguez-Morales

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

Over the last months and weeks of the pandemic of the Coronavirus Disease 2019 (COVID-19) (January-May 2020) caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been a significant hope for the development of vaccines against this emerging coronavirus. Dozens of vaccine candidates are currently under assessment in clinical trials already recruiting patients, then there is a real chance to have effective biologicals in relatively short-time, compared to other vaccines.

Original language	English
Pages (from-to)	450-453
Number of pages	4
Journal	Journal of Infection in Developing Countries
Volume	14
Issue number	5
DOIs	https://doi.org/10.3855/jidc.12744
State	Published - 31 May 2020
Externally published	Yes

Keywords

COVID-19
SARS-CoV-2
Vaccines

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3855/jidc.12744

Cite this

@article{096e9e38bfde413aa448ae9aa6bc2cb4,

title = "A vaccine is not too far for COVID-19",

abstract = "Over the last months and weeks of the pandemic of the Coronavirus Disease 2019 (COVID-19) (January-May 2020) caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been a significant hope for the development of vaccines against this emerging coronavirus. Dozens of vaccine candidates are currently under assessment in clinical trials already recruiting patients, then there is a real chance to have effective biologicals in relatively short-time, compared to other vaccines.",

keywords = "COVID-19, SARS-CoV-2, Vaccines",

author = "Patel, {Shailesh Kumar} and Mamta Pathak and Ruchi Tiwari and Yatoo, {Mohd Iqbal} and Malik, {Yashpal Singh} and Ranjit Sah and Rabaan, {Ali A.} and Khan Sharun and Kuldeep Dhama and Bonilla-Aldana, {D. Katterine} and Rodriguez-Morales, {Alfonso J.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2020 Patel et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",

year = "2020",

month = may,

day = "31",

doi = "10.3855/jidc.12744",

language = "Ingl{\'e}s",

volume = "14",

pages = "450--453",

journal = "Journal of Infection in Developing Countries",

issn = "2036-6590",

publisher = "Journal of Infection in Developing Countries",

number = "5",

}

TY - JOUR

T1 - A vaccine is not too far for COVID-19

AU - Patel, Shailesh Kumar

AU - Pathak, Mamta

AU - Tiwari, Ruchi

AU - Yatoo, Mohd Iqbal

AU - Malik, Yashpal Singh

AU - Sah, Ranjit

AU - Rabaan, Ali A.

AU - Sharun, Khan

AU - Dhama, Kuldeep

AU - Bonilla-Aldana, D. Katterine

AU - Rodriguez-Morales, Alfonso J.

N1 - Publisher Copyright: Copyright © 2020 Patel et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2020/5/31

Y1 - 2020/5/31

N2 - Over the last months and weeks of the pandemic of the Coronavirus Disease 2019 (COVID-19) (January-May 2020) caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been a significant hope for the development of vaccines against this emerging coronavirus. Dozens of vaccine candidates are currently under assessment in clinical trials already recruiting patients, then there is a real chance to have effective biologicals in relatively short-time, compared to other vaccines.

AB - Over the last months and weeks of the pandemic of the Coronavirus Disease 2019 (COVID-19) (January-May 2020) caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been a significant hope for the development of vaccines against this emerging coronavirus. Dozens of vaccine candidates are currently under assessment in clinical trials already recruiting patients, then there is a real chance to have effective biologicals in relatively short-time, compared to other vaccines.

KW - COVID-19

KW - SARS-CoV-2

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=85086354141&partnerID=8YFLogxK

U2 - 10.3855/jidc.12744

DO - 10.3855/jidc.12744

M3 - Artículo

C2 - 32525830

AN - SCOPUS:85086354141

SN - 2036-6590

VL - 14

SP - 450

EP - 453

JO - Journal of Infection in Developing Countries

JF - Journal of Infection in Developing Countries

IS - 5

ER -

A vaccine is not too far for COVID-19

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this